Pertussis vaccine performance in an epidemic year - Oregon, 2012

Clinical Infectious Diseases

Volumn 59, Issue 2, 2014, Pages 261-263

  Liko, Juventila ^a   Robison, Steve G ^a   Cieslak, Paul R ^b  

^a Oregon Immunization Program   (United States)

^b OREGON HEALTH AUTHORITY   (United States)

Author keywords

vaccine effectiveness

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONFIDENCE INTERVAL; DRUG EFFICACY; EPIDEMIC; GROUPS BY AGE; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; UNITED STATES; FEMALE; IMMUNOLOGY; MALE; PRESCHOOL CHILD; TREATMENT OUTCOME; WHOOPING COUGH;

ADOLESCENT; CHILD, PRESCHOOL; EPIDEMICS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; OREGON; PERTUSSIS VACCINE; TREATMENT OUTCOME; WHOOPING COUGH;

EID: 84904009187     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu273     Document Type: Article

References (12)

1. Cherry JD. Pertussis: Challenges today and for the future. PLoS Pathog 2013; 9:e1003418.
2. Council of State and Territorial Epidemiologists (CSTE). Public health surveillance, control, and prevention of pertussis. CSTE position statement 09-ID-51. Atlanta, GA: CSTE, 2000. Available at: Http://wwwn. cdc.gov/nndss/script/casedef.aspx?CondYrID=795&DatePub=1/1/ 2010 12:00:00 AM. Accessed 14 January 2014.
3. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10:212-41. (Pubitemid 18262846)
4. Hightower AW, Orenstein WA, Martin SM. Recommendations for the use of Taylor series confidence intervals for estimates of vaccine efficacy. Bull World Health Organ 1988; 66:99-105.
5. Centers for Disease Control and Prevention. Pertussis epidemic- Washington. MMWR Morb Mortal Wkly Rep 2012; 61:517-22.
6. Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 2013; 368:581-2.
7. Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines. 5th ed. Philadelphia:W.B. Saunders Co, 2008: 467-517.
8. Acosta AM. Tdap vaccine effectiveness among adolescents inWashington. In: 62nd Annual Epidemic Intelligence Service Conference, Atlanta, GA, 24 April 2013. Available at: Http://www.cdc.gov/eis/downloads/ 2013-EIS-Conference.pdf. Accessed 14 January 2014.
9. Wei SC, Tatti K, Cushing K, et al. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Clin Infect Dis. 2010; 51:315-21.
10. US Community Services Task Force. Guide to community preventive services. Increasing appropriate vaccination: Immunization information systems, 2010. Available at: Http://www.thecommunityguide.org/vaccines/ imminfosystems.html. Accessed 14 January 2014.
11. Stokley S, Rodewald LE, Maes EF. The impact of record scattering on the measurement of immunization coverage. Pediatrics 2001; 107: 91-96. (Pubitemid 32055421)
12. Glanz JM, McClure DL, Magid DJ, et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics 2009; 123:1446-51. doi:10.1542/peds.2008-2150.